Hematopoietic Cell Growth Factors

DBCAT000086Pharmacologic class

These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this... A DrugBank category of 22 drugs. 13 of them are approved.

Also known as: Hematopoietic Cell Growth Factor · Hematopoietic CGF · Hematopoietic Stem Cell Stimulators · Hematopoietic Stem Cell-Activating Factors · Hematopoietic-CGF
Drugs: Ancestim
Balugrastim
Darbepoetin alfa
Efbemalenograstim alfa
Eflapegrastim
Epoetin beta
Epoetin delta
Erythropoietin
Filgrastim
Lenograstim
Leridistim
Lipegfilgrastim
Maxy-G34
Mecapegfilgrastim
Methoxy polyethylene glycol-epoetin beta
Molgramostim
Muplestim
Pegfilgrastim
Regramostim
Romiplostim
Sargramostim
Thrombopoietin

What you can answer from here — as of August 24, 2016

22DrugsEach linked to its full drug card

Listed above

17Drug targetsEvery drug–target pair in the class, with bond type

2,699Marketed productsAcross the regions we cover, with dosage forms and routes

5Routes of administrationHow the drugs in this class are given

Which targets do Hematopoietic Cell Growth Factors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account